K. Yamamoto et al., ESTABLISHMENT OF A NOVEL HUMAN ACUTE MYELOBLASTIC-LEUKEMIA CELL-LINE (YNH-1) WITH T(16-21), T(1-16) AND 12Q13 TRANSLOCATIONS, Leukemia, 11(4), 1997, pp. 599-608
The t(16;21)(p11;q22) translocation is a non-random chromosomal aberra
tion observed in several types of human acute myeloblastic leukemia (A
ML), whereas the der(16)t(1;16) and chromosome rearrangements at 12q13
are frequently found in solid tumors. A novel cell line YNH-1 was est
ablished from peripheral blood cells of a 46-year-old male with AML (M
1) carrying t(16;21) and t(1;16) translocations. YNH-1 has been mainta
ined with a doubling time of 82 h for more than 20 months as a granulo
cyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-
stimulating factor (GM-CSF) and interleukin-3 (IL-3) dependent line. M
orphologically YNH-1 cells were free-floating immature myeloblasts wit
h lobulated nuclei and vacuoles in the cytoplasm. They were positive f
or myeloperoxidase but negative for alpha-naphthyl butylate esterase a
nd chloroacetate esterase stainings. In surface marker analysis YNH-1
cells were positive for CD13, CD33 and CD34. Chromosomal analysis show
ed 46, XY, der(16)t(16;21)(p11;q22)t(1;16) (912;q13), der(21)t(16;21)(
p11;q22), der(6)t(6;12)(q13;q13), der(12)t(6;12)(q21;q13). These trans
locations were confirmed by fluorescence in situ hybridization (FISH)
studies with the ERG-YAC clone and chromosome-specific DNA libraries.
Both the FUS/ERG and ERG/FUS chimeric transcripts were identified by r
everse transcriptase-polymerase chain reaction (RT-PCR) analysis. Thus
, YNH-1 could be a useful tool for elucidating the pathophysiology and
molecular mechanism in AML with t(16;21),t(1;16) and 12q13 translocat
ions.